Abbott shares were down 3.9% in morning trading on mixed results for the heart-failure drug, levosimendan or Simdax, and another drug, Tricor, which was aimed at further reducing heart problems in diabetics on top of conventional therapy.

FORBES: Magazine Article

Abbott (nyse: ABT - news - people ) shares were down 3.9% in morning trading on mixed results for the heart-failure drug, levosimendan or Simdax, and another drug, Tricor, which was aimed at further reducing heart problems in diabetics on top of conventional therapy.

FORBES: Open Questions For Heart Failure Drugs

If he wants to scapegoat Congress and the Federal government for shorting cities on housing, Bloomberg has an immense repertoire to choose from: the flat out failure of foreclosure policies, anti-urban transportation funding, lending that stifles mixed-use developments, and so on.

FORBES: Mayor Bloomberg Rezones the Mortgage Crisis